- Home
- SGHT vs BNY Comparison
SGHT vs BNY Comparison
Compare SGHT & BNY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SGHT
- BNY
- Stock Information
- Founded
- SGHT 2011
- BNY 2001
- Country
- SGHT United States
- BNY United States
- Employees
- SGHT N/A
- BNY N/A
- Industry
- SGHT Medical Specialities
- BNY Trusts Except Educational Religious and Charitable
- Sector
- SGHT Health Care
- BNY Finance
- Exchange
- SGHT Nasdaq
- BNY Nasdaq
- Market Cap
- SGHT 217.7M
- BNY 232.5M
- IPO Year
- SGHT 2021
- BNY N/A
- Fundamental
- Price
- SGHT $4.22
- BNY $9.67
- Analyst Decision
- SGHT Buy
- BNY
- Analyst Count
- SGHT 8
- BNY 0
- Target Price
- SGHT $4.01
- BNY N/A
- AVG Volume (30 Days)
- SGHT 176.9K
- BNY 52.7K
- Earning Date
- SGHT 07-31-2025
- BNY 01-01-0001
- Dividend Yield
- SGHT N/A
- BNY 3.93%
- EPS Growth
- SGHT N/A
- BNY N/A
- EPS
- SGHT N/A
- BNY N/A
- Revenue
- SGHT $78,109,000.00
- BNY N/A
- Revenue This Year
- SGHT N/A
- BNY N/A
- Revenue Next Year
- SGHT $11.60
- BNY N/A
- P/E Ratio
- SGHT N/A
- BNY N/A
- Revenue Growth
- SGHT N/A
- BNY N/A
- 52 Week Low
- SGHT $2.03
- BNY $8.60
- 52 Week High
- SGHT $8.45
- BNY $10.80
- Technical
- Relative Strength Index (RSI)
- SGHT 61.79
- BNY 49.45
- Support Level
- SGHT $4.02
- BNY $9.59
- Resistance Level
- SGHT $4.46
- BNY $9.69
- Average True Range (ATR)
- SGHT 0.22
- BNY 0.08
- MACD
- SGHT -0.03
- BNY 0.01
- Stochastic Oscillator
- SGHT 71.43
- BNY 55.26
About SGHT Sight Sciences Inc.
Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. Its Surgical Glaucoma segment's product portfolio features the OMNI Surgical System, a device that facilitates the performance of both canaloplasty and trabeculotomy with a single device and single corneal incision to reduce intraocular pressure in adult patients with primary open-angle glaucoma. The company's Dry Eye segment's product portfolio consists of the TearCare System for ophthalmologists and optometrists. It derives key revenue from the Surgical Glaucoma segment.
About BNY BlackRock New York Municipal Income Trust
Blackrock NY Municipal Income Tr investment objective is to provide shareholders with as high a level of current income exempt from U.S. federal income taxes and New York State and New York City personal income taxes as is consistent with its investment policies and prudent investment management.